Table 2.

Access characteristics and events during the study

101 HD Accesses, 96 Patients
Length of renal replacement therapy with index access (median days) prior to CAS treatment	693 (IQR 429 – 1285)
Radiocephalic Arteriovenous Fistula/e	2 (1.9%)
Brachiocephalic Arteriovenous Fistula/e	99 (98.1%)
Follow-up Period (days)	277 (IQR 135 – 920)
Main indication for first intervention (101 HD Accesses)
Raised pressure during dialysis / prolonged puncture site bleeding	56 (55.3%)
Aneurysmal changes in conduit	28 (27.7%)
Poor URR	17 (16.9%)
Cephalic Arch Stenosis Distribution Pattern in Percentage (101 HD Accesses) (Fig. 1)
A – ascending	8%
B – apical	28.2%
C – confluence	27.6%
D – multifocal	36.2%
Events during the Study (192 interventions)
Access thrombosis	12 (6.3%)
Switch to different arteriovenous HD access	36 (18.8%)
TCVC insertion	22 (11.4%)